期刊文献+

三阴性乳腺癌放射治疗相关机制的研究进展 被引量:4

The related mechanism of radiotherapy in triple-negative breast cancer
下载PDF
导出
摘要 放射治疗是乳腺癌局部治疗的主要手段之一。三阴性乳腺癌(triple-negative breast cancer,TNBC)作为乳腺癌分子亚型的一个分型,其分子及生物学行为具有多方面特殊性,并存在多个分子靶点的异常,这些异常分子靶点可通过不同机制影响肿瘤对电离辐射的反应,从而调节三阴性乳腺癌的放疗敏感性。现就TNBC的放射治疗及其放疗敏感性相关分子靶点的研究新进展予以综述。 Radiotherapy is one of the main means of local treatment of breast cancer. Triple negative breast cancer (TNBC) as a molecular subtypes of breast cancer, its biological behavior is special and existing multiple molecular targets, these molecular targets inlfuence the response of ionization radiation through different mechanisms and regulate radiotherapy sensitivity of TNBC This article reviewed the recent advances in radiotherapy and radiosensitivity related molecular targets of TNBC.
作者 李冰馨 傅深
出处 《中国癌症杂志》 CAS CSCD 北大核心 2014年第11期865-870,共6页 China Oncology
关键词 三阴性乳腺癌 放射治疗 放疗敏感性 分子靶点 Triple-negative breast cancer Radiotherapy Radiosensitivity Biomarker
  • 相关文献

参考文献35

  • 1VALENTIN M D, DASILVA S D, PRIV AT M, et al. Molecular insights on basal-like breast cancer [J]. Breast Cancer Res Treat, 2012,134(1): 21-30. 被引量:1
  • 2ABDULKARIM B S, CUARTERO J, HANSON J, et al. Increased risk of locoregional recurrence for women with T'_2No triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy [J]. J Clin Oncol, 2011,29(21): 2852-2858. 被引量:1
  • 3GOLDHIRSCH A, WOOD W C, COATES A S, et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [J]. Ann Oncol, 2011, 22(8): 1736-1747. 被引量:1
  • 4OAKMAN C, VIALE G, Dr LEO A. Management of triple negative breast cancer [J]. Breast, 2010,19(5): 312-321. 被引量:1
  • 5GAZINSKA P, GRIGORIADIS A, BROWN J P, et al. Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistocbemistry and transcriptional profiles [J]. Mod Pathol, 2013, 26: 955-966. 被引量:1
  • 6NIELSEN T 0, HSU F D, JENSEN K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma [J]. Clin Cancer Res, 2004,10(16): 5367-5374. 被引量:1
  • 7DENT R, TRUDEAU M, PRITCHARD K I, et al. Triplenegati ve breast cancer: clinical features and pattern of recurrence [J]. Clin Cancer Res, 2007, 13(15 Pt 1): 4429- 4434. 被引量:1
  • 8DE GIORGI U, ROSTI G, FRASSINETI L, et al. High-dose chemotherapy for triple negative breast cancer [J]. Ann Oncol, 2007, 18(1): 202-203. 被引量:1
  • 9ABDULKARIM B S, CUARTERO , HANSON, J, et al. Increased risk of locoregional recurrence for women with T,_ 2No triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. [J] J Clin Oncol, 2011, 29(21): 2852-2858. 被引量:1
  • 10GUru S, MICHIELS S, ANDRE F, et al. Molecular suBclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement [J]. Ann Oncol, 2012, 23(12): 2997-3006. 被引量:1

二级参考文献49

  • 1Nakata E, Mason KA, Hunter N, et al. Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors[J]. Int J Radiat Oncol Biol Phys , 2004 , 58(2):369-375. 被引量:1
  • 2Grosch S, Maier TJ, Schiffmann S, et al. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors [J]. J Natl Cancer Inst, 2006, 98(11):736-747. 被引量:1
  • 3Katoh Y, Katoh M. Comparative integromics on VEGF family members [J]. Int J Oncol, 2006,28(6):1585-1589. 被引量:1
  • 4Soumaoro LT, Uetake H, Takagi Y, et al. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis[J]. Dis Colon Rectum, 2006, 49(3):392-398. 被引量:1
  • 5Gately s, Li ww. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy [J]. Semin Oncol,2004,31 (2 Suppl 7): 2-11. 被引量:1
  • 6Tessner TG, Muhale F, Schloemann S, et al. Ionizing radiation up-regulates cyclooxygenase-2 in I407 cells through p38 mitogen-activated protein kinase[J].Carcinogenesis, 2004,25(1 ):37-45. 被引量:1
  • 7Raju U, Nakata E , Yang P, et al . In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations [J]. Int J Radiat Oncol Biol Phys, 2002,54(3): 886-894. 被引量:1
  • 8PEROU C M, SORLIE T, EISEN M B, et al. Molecular portraits of human hreast tumours [J]. Nature, 2000, 406(6797): 747-752. 被引量:1
  • 9SORLIE T, TIBSHIRANI R, PARKER J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets [J]. Proc Nat! Acad Sci USA, 2003, 100(14): 8418-8423. 被引量:1
  • 10SORLIE T, PEROU C M, TIBSHIRANI R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications [J]. Proc Natl Acad Sci USA, 2001, 98(19): 10869-10874. 被引量:1

共引文献39

同被引文献69

  • 1马涛,张君莹,吴建中,唐金海.miR-342-3p对三阴性乳腺癌化疗敏感性的影响[J].中南大学学报(医学版),2014,39(5):488-495. 被引量:8
  • 2Meena M.Radiation therapy in the locoregional treatment of triple-negative breast cancer[J].Lancet Oncol,2015,16(3):113-122. 被引量:1
  • 3Boyle P.Triple-negative breast cancer:epidemiological considerations and recommendations[J].Ann Oncol,2012,23(6):7-12. 被引量:1
  • 4Sioshansi S,Ehdaivand S,Cramer C,et al.Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy[J].Cancer,2012,118(16):3893-3898. 被引量:1
  • 5Part A,Adamo B,Cheang MC,et al.Molecular characterization of basal-like and non-basal-like triple-negative berast cancer[J].Oncologist,2013,18(2):123-133. 被引量:1
  • 6Lehmann BD,Bauer JA,Chen X,et al.Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies[J].J Clin Invest,2011,121(7):2750-2767. 被引量:1
  • 7Lehmann BD,Pietenpol JA.Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes[J].J Pathol,2014,232(2):142-150. 被引量:1
  • 8Lehmann BD,Bauer JA,Chen X,et al.Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies[J]. J Clin Invest,2011,121(7):2750-2767. 被引量:1
  • 9Gazinska P,Grigoriadis A,Brown JP,et al.Comparison of basal-like triple-negative breast cancer defined by morphology,immunohistochemistry and transcriptional profiles[J].Mod Pathol,2013,26(7):955-966. 被引量:1
  • 10Perou CM.Molecular stratification of triple-negative breast cancers[J].Oncologist,2010,15(5):39-48. 被引量:1

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部